Intent of Surgery for IPMN
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorNYU Langone Health
About this trial
This multicenter retrospective observational cohort study seeks to:
1. Classify surgical intent in patients with resected Intraductal Papillary Mucinous Neoplasms (IPMN) and quantify the proportion of IPMN-associated cancers diagnosed as overt pancreatic cancer with incidental IPMN association on pathology. 2. Compare clinicopathologic features and outcomes between surveillance-detected and incidentally detected IPMN-derived pancreatic cancers. 3. Revise and redefine risk features limited to patients undergoing surgery for IPMN-related indications, identifying optimal predictors of malignant IPMN (high-grade dysplasia or invasive cancer).
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
All patients (18 years old of greater) who underwent surgical resection for IPMN (including low-, high-grade dysplasia, or invasive carcinoma) between July 1, 2015 and July 1, 2025.
Disqualifiers
Patients with concomitant pancreatic ductal adenocarcinoma (PDAC)
Trial population
Patients (18 years old of greater) who underwent surgical resection for IPMN (including low-, high-grade dysplasia, or invasive carcinoma) between July 1, 2015 and July 1, 2025.
Trial design
Design model
Cohort
Time perspective
Retrospective
Treatments tested in this trial
Not listed
Trial groups
2,000 Participants
are grouped into 1 trial groupGroup A: Patients who underwent surgical resection for IPMN
Trial outcomes
Primary outcomes
1
Grade of IPMN on Final Pathology
Time frame
Day 0 (Retrospective Analysis)Secondary outcomes
1
Recurrence Free Survival
Length of time from surgery for IPMN to recurrence.
Time frame
Day 0 (Retrospective Analysis)2
Overall Survival
Length of time from surgery to death due to any cause.
Time frame
Day 0 (Retrospective Analysis)Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov